Medicine and Dentistry
Parkinson's Disease
100%
Diseases
25%
Infection
18%
Gut Microbiome
18%
COVID-19
18%
Severe Acute Respiratory Syndrome Coronavirus 2
18%
Unified Parkinson's Disease Rating Scale
15%
Myelodysplastic Syndrome
15%
Comorbidity
13%
Progressive Supranuclear Palsy
12%
Prevalence
12%
Outpatient
10%
Atypical Parkinsonism
10%
Clinician
9%
Health Care
9%
Early Diagnosis
9%
Systematic Review
9%
Mild Cognitive Impairment
9%
microRNA
9%
Cardiovascular System
9%
Observational Study
9%
Metabolomics
9%
Physiotherapy
9%
Disease Duration
8%
Cohort Analysis
7%
Nutritional Status
6%
Long-Term Care
5%
Patient-Reported Outcome
5%
Cardiovascular Disease
5%
Keyphrases
COVID-19 Immunity
18%
Parkinson's Disease
18%
Xanthine
9%
Metabolic Function
9%
Relevant Changes
9%
Device Therapy
9%
Self-stigma
9%
GBA1
9%
Disease Duration
9%
Secondary Data Analysis
9%
COVID-19 Pandemic Impact
9%
Parkinson
9%
COVID-19 Related
9%
Fluid Intake
9%
Behavior Modification
9%
Comprehensive Approach
9%
Disease Effects
9%
People with Dementia
9%
Early Diagnosis
9%
Environmental Modification
9%
Long-read Sequencing
9%
Luxembourgish
9%
Priority Setting Partnership
9%
International Context
9%
Cardiovascular History
9%
Major Risk Factors
9%
Variant Severity
9%
Data Management
9%
COVID-19 Infection
9%
Luxembourg
9%
Cross-cohort
9%
Motor Fluctuations
9%
Interpretable Machine Learning
9%
Advanced PD
8%
Period Prevalence
6%
Self-perceived
5%
